Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant in the AASK Cohort Study
Ability and willingness to provide informed consent
Completion of a technically adequate ABPM at CO48 AASK cohort study visit.
Participants must have had at least 2 visits in the last 12 months of the Cohort Study (July 1 2006 to June 1 2007)
The average of last two BPs measured at least one week apart in the Cohort Study must be less than or equal to 140/90 mm Hg. This would exclude a small percentage of the AASK cohort population; however, it would enroll a group of participants with stable BP who should not require adjustments to their antihypertensive medications during the course of this study.
Antihypertensive medications at baseline visit: This refers to the participant's antihypertensive regimen at the time of the baseline visit ; the transition period may be used to adjust the participant's antihypertensive regimen to meet these criteria, based on the clinical judgement of the site investigator.
You may not be if
Arm circumference greater than 50 cms.
ESRD requiring renal replacement therapy or kidney transplantation
Institutionalized participants
Shift workers working at night
MI or CVA within 3 months of AASK Cohort close out visit
Participants with known ejection fraction less than 40%
Females known to be pregnant or lactating
Participants likely to reach end stage renal disease within the next six weeks, in the judgement of the site investigator
